Patent assignee · US · COMPANY

Syntimmune, Inc.

2Patents
2Active
2Granted
40Portfolio score

Filing activity: Apr 25, 2017 → Nov 13, 2017

Most-cited patents

PatentTitleAreaCited byStatus
US10822417B2 Humanized affinity matured anti-FcRn antibodies Physics 0 Active
US10626175B2 Humanized affinity matured anti-FcRn antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.